Antimicrobial surgical sutures are coated or impregnated with chemicals harmful to microorganisms, which interfere with vital cell processes within bacterial cells. Antimicrobial coatings stop bacterial adhesion and growth on suture materials. The antimicrobial surgical suture market report emphasizes key factors impacting the market and showcases the developments of prominent players.
The antimicrobial surgical suture market in North America is expected to register a CAGR of 9.6% during 2023–2031. North America dominates the antimicrobial surgical suture market. The increasing surgical procedures and the rising spending on cosmetic or plastic surgeries in the US are propelling the market growth. As per the American Society of Plastic Surgeons, US$ 16.5 billion was spent on cosmetic procedures in the US in 2018. Medical facilities in the Mountain/Pacific region in the US are more famous for their expertise in cosmetic surgeries. More than 1.5 million surgical cosmetic operations and more than 5.5 million nonsurgical procedures were carried out in the US.
Cardiovascular diseases (CVDs) and stroke produce immense health burdens in the US. According to the American College of Cardiology’s reports, ~800,000 deaths were noted in the US. Coronary heart disease is the primary cause of death, followed by heart stroke and heart failure. However, deaths due to coronary heart disease have declined over the past decade due to the awareness of advanced medical diagnosis, treatments, medical insurance, and reimbursements. Therefore, the rise in medical therapies has led to an increase in cardiovascular, orthopedics, and cosmetic surgeries, in turn, fueling the need for antimicrobial surgical sutures in the US.
Asia Pacific is expected to record the highest CAGR in the antimicrobial surgical suture market during the forecast period. The market in this region is expected to grow owing to factors such as the rising number of plastic surgeries and increasing demand for medical tourism in emerging economies such as China and India. Moreover, an upsurge in research studies and healthcare expenditure is anticipated to fuel the antimicrobial surgical suture market growth during the forecast period.
Increasing Cases of Chronic Wounds and Surgeries Bolsters Antimicrobial Surgical Suture Market Growth
According to the American College of Surgeons, ~1–2% of individuals in the world are likely to experience chronic wounds once in their lifetime. Similarly, as per the estimates from the Centers for Disease Control and Prevention (CDC), ~385,000 sharps injuries occur among healthcare workers in the US every year, and the number is likely to reach up to 800,000 injuries within one year. Besides sharp injuries, the number of other types of workplace or occupational injuries is increasing worldwide. According to the International Labor Organization, ~2.3 million people experience work-related injuries every year, affecting their health and quality of life. The soaring burden of chronic wounds eventually propels the demand for advanced wound care management methods to substantially reduce the financial burden from national healthcare systems. Various countries spend significant amounts of money on treating injuries and avoiding associated risks. For instance, in the US, the healthcare system spends over US$ 25 billion on treating wounds and related complications every year. Therefore, with the increasing incidence of chronic wounds, the demand for antimicrobial surgical sutures is also increasing worldwide.
Antimicrobial Surgical Suture Market: Segment Overview
Based on type, the antimicrobial surgical suture market is classified into triclosan antimicrobial suture and chlorhexidine antimicrobial suture. The triclosan antimicrobial suture segment held a larger share of the market in 2023, and it is further anticipated to register a higher CAGR during the forecast period.
Based on raw material, the antimicrobial surgical suture market is classified into polyglactin 910 antimicrobial suture, poliglecaprone 25, and polyglycolic acid. The polyglactin 910 antimicrobial suture segment held the largest share of the market in 2023, and it is further anticipated to register the highest CAGR during the forecast period.
By application, the market is segmented into cardiovascular surgery, general surgery, ophthalmic surgery, gynecological surgery, orthopedic surgery, plastic surgery, veterinary surgery, dental surgery, and others. The cardiovascular surgery segment held the largest share of the market in 2023; it is further anticipated to register the highest CAGR during 2023–2031.
Based on end user, the antimicrobial surgical suture market is divided into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2023. The pluripotent stem cells segment is anticipated to register the highest CAGR during the forecast period.
Antimicrobial Surgical Suture Market: Competitive Landscape and Key Developments
TI Medical; Healthium Medtech Limited; Meril Life Sciences Pvt Ltd; Unilene; Johnson & Johnson; Boz Medical; Futura Surgicare Pvt Ltd (Dolphin Sutures); Cencora, Inc. (AmerisourceBergen Corporation); Advanced MedTech Solutions Pvt. Ltd., and Internacional Farmacéutica SA. are among the key companies operating in the antimicrobial surgical suture market.
